Skandinaviska Enskilda Banken AB publ Sells 4,500 Shares of Hawkins, Inc. $HWKN

Skandinaviska Enskilda Banken AB publ decreased its holdings in shares of Hawkins, Inc. (NASDAQ:HWKN) by 25.9% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 12,881 shares of the specialty chemicals company’s stock after selling 4,500 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Hawkins were worth $1,831,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in shares of Hawkins during the second quarter valued at about $31,000. Brooklyn Investment Group lifted its position in Hawkins by 533.3% in the 1st quarter. Brooklyn Investment Group now owns 266 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 224 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in Hawkins during the 1st quarter valued at about $42,000. Russell Investments Group Ltd. bought a new stake in Hawkins during the 1st quarter worth approximately $52,000. Finally, Quantbot Technologies LP purchased a new stake in shares of Hawkins in the first quarter worth approximately $57,000. 69.71% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Hawkins news, VP Drew M. Grahek bought 1,587 shares of the stock in a transaction on Monday, November 3rd. The shares were acquired at an average price of $126.34 per share, with a total value of $200,501.58. Following the acquisition, the vice president directly owned 39,640 shares of the company’s stock, valued at $5,008,117.60. The trade was a 4.17% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 4.10% of the company’s stock.

Hawkins Trading Up 1.2%

Shares of HWKN opened at $131.63 on Tuesday. Hawkins, Inc. has a fifty-two week low of $98.30 and a fifty-two week high of $186.15. The business has a 50-day moving average of $152.26 and a 200 day moving average of $154.08. The firm has a market cap of $2.75 billion, a P/E ratio of 33.07, a price-to-earnings-growth ratio of 2.25 and a beta of 0.82. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.45 and a current ratio of 2.31.

Hawkins (NASDAQ:HWKN) last issued its earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share for the quarter, missing analysts’ consensus estimates of $1.24 by ($0.16). The business had revenue of $280.43 million for the quarter, compared to the consensus estimate of $284.42 million. Hawkins had a return on equity of 17.79% and a net margin of 7.95%. As a group, research analysts forecast that Hawkins, Inc. will post 4 EPS for the current year.

Hawkins Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Friday, November 14th were issued a $0.19 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $0.76 annualized dividend and a yield of 0.6%. Hawkins’s dividend payout ratio (DPR) is 19.10%.

Analysts Set New Price Targets

Several brokerages recently issued reports on HWKN. Zacks Research cut Hawkins from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 4th. Weiss Ratings restated a “buy (b-)” rating on shares of Hawkins in a research note on Monday, November 24th. Finally, BWS Financial reiterated a “buy” rating and issued a $200.00 target price on shares of Hawkins in a research note on Monday, November 3rd. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $162.50.

Hawkins Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.